Tag Archives: catgut sutures
“Made in China,” Yi Xie market need to break the three bottleneck
Although the rapid development of China\\ s medical device industry, prospects, but experts believe that if China\\ s medical device companies can not break through the current development of some of the bottlenecks will be opportunities for economic development. According to the statistical report, in the next few years, global medical device market will be 4% to 6% growth in 2011, the global medical equipment market will reach $ 312 billion. China\\ s medical device market in 2010, topped 100 billion yuan, becoming the world\\ s second largest after the U.S. medical device market.
First, the number of medical device companies, small scale, weak competitiveness
And China\\ s pharmaceutical industry is similar to China\\ s medical device industry, there are number of small scale, industry concentration is low, inadequate investment in research, innovation, low problem. Jiang Feng said that although the number of medical device companies are more, but ninety percent of small businesses, selling billions of dollars of business a few, most companies can only survive in the market for low-end, or to provide spare parts for foreign companies .
Experts believe that the medical device industry is a multi-disciplinary, knowledge-intensive, capital-intensive high-tech industries, high barriers to entry, our businesses must be talent, capital, technology, management, reinforce their own strength, can stand in the competition position.
Second, the domestic medical equipment is not high tech, high-end market occupied by foreign companies
Statistics show that China-made high-end medical device market share in less than 1 / 3, the product life and product quality with the foreign companies have a certain gap. From 2010, China\\ s medical device market, the basic composition, high-end products make up only 25%, while the low-end products accounted for 75%. The other hand, the international medical device market, the high-end products are generally accounted for 55% of the share of low-end products make up only 45%. Although China\\ s one-time supplies, dental materials, wheelchairs, medical supplies and surgical dressings and other products popular and dependable capacity ranks first in the world, but there is no doubt that these products are low value-added, high energy-consuming products.
Chinese Medicines and Health Products Import and Export Chamber of Commerce, said medical director Cai Tianzhi, and foreign medical device companies, domestic medical device companies vulnerable obvious. For CT equipment, for example, in 2010 GE, Siemens, Philips, Toshiba, Neusoft and five companies account for the domestic market share up to 92%; MRI equipment, GE, Siemens, Philips three occupy more than 50% domestic market share .
Third, the shortage of funds, and financing difficulties
Jiang Feng said China\\ s medical device companies less physical capital, asset less, causing a serious shortage of R & D investment, accounting for only 3%. Within the main source of domestic finance companies, especially small and medium private enterprises apply for grants and loans more difficult, basically there are no other financial support for science and technology. VCs are also a lot of problems, such as the PE-based, short-sighted behavior, mostly oriented rather than technology-oriented market; lack of real venture and angel capital; single exit channel, resulting in extensive use for gambling strategy, corporate executives overwhelmed, poor sustainability performance, reduce R & D and other long-term investment.
Therefore, experts suggest that, in order to guide the Ministry of Science and Innovation Fund to mobilize social capital to participate in the establishment of professional industry fund independent projects with the Ministry of Science and matched to support business innovation and development. At the same time, recommended the establishment of specialized medical equipment results into evaluation platform, with the financial services technology. In addition, local governments and Technology Park should support leading enterprises in the field of mergers and acquisitions, and promote the formation of industrial clusters.
Medical Devices extend to the multi-
Medical device market will diversify product mix. In recent years, with economic development, people\\ s lives become more affluent, the nation\\ s demands for the quality of their own health is also increasing the demand for increasingly diversified medical device, which promote medical products in China gradually extended to the multi-direction, the product structure constantly adjust the market is expanding, the market will be large numbers of home-based, portable, network-based home medical electronics equipment product.
Multinational companies to enter the domestic market accelerated. In order to further expand the potential of the huge Chinese market, take advantage of China\\ s labor resources, multinational companies will set up production bases in China to increase research and development institutions, in order to achieve the development, production and sales of local integrated operation. Such as, GE has been set up in Shanghai and Beijing production, R & D institutions, in our whole field of high-end medical equipment market share of about 50%. Siemens, Philips, Toshiba and other companies are also increasing investment in China, in addition to high-end Chinese medical device market competition, but also some rather trying to expand the potential of low-end market. Jiang Feng believes that with the Chinese medical device market, the further development of multinationals will further increase investment in the Chinese market will be through mergers, direct factories, means of further expanding the product line for the domestic market share, China\\ s various types Medical companies will face huge challenges.
Foreign capital will further enter the Chinese market. At present, more and more difficult in new drug development, cost, and cycle continues to improve, extend, continue in the latter part of the drug failed clinical trials, for the health industry, investors and operators are beginning to focus into the field of medical devices, quality resources in a battle of medical devices are quietly set off the wave of mergers and consolidation, medical diagnostic technology and services are becoming a hot investment and mergers and acquisitions.
Medical device market ushered in a favorable development opportunities
China\\ s medical device market has developed rapidly in recent years. According to the China Medical Device Industry Association statistics, the end of 2010, China\\ s medical equipment related to the number of over 14,000 enterprises, of which 99% of non-public economy type. Medical device industry sales in recent years, the average growth rate of more than 20%. In particular, low-end medical devices in a variety of products (such as sanitary materials, disposable hospital supplies, infusion, B-, ventilator, general surgical instruments like surgical instruments and laser, etc.), China\\ s output ranks first in the world.
Increased demand in emerging markets, reducing the need for hospitalization and the arrival of aging society, but also to the domestic medical equipment industry provide a strong impetus.
Cf international medical device market, China\\ s medical device industry still have a huge space. Ministry of Science and medical device industry technology innovation strategic alliance chairman, China Medical Device Industry Association vice president Jiang Feng said that in developed countries, the output value associated with the health industry accounted for 8% -15% of GDP, while China accounted for only 2% ; equipment and drugs in the market share, the developed countries of about 1:1, 1:3 in China, accounting for less than equipment; in the global market share, 72% of U.S. and Japanese Alder, China accounted for only 5%; domestic market share, the developed countries accounted for 70%, China 30%.
Technological progress and upgrading of equipment, but also will bring to market demand. Analysis of industry experts, along with technological progress, China\\ s medical device product structure will be adjusted, medical device functions from a simple diagnosis, treatment, laboratory-based to diagnosis, treatment, testing, analysis, rehabilitation, physical therapy, massage, health and other multi- extension of medical devices will continue to adjust product structure, so the market continues to expand. Meanwhile, with the continued use of our high-tech, medical devices so that the sensitivity, applicability, early diagnosis, trace analysis, diagnosis and treatment of the specificity and efficiency, etc. has been greatly improved, which is bound to promote the early retirement of a large number of old products and trigger a new medical device market.
In addition, the next few years, China\\ s procurement of medical equipment, medical equipment will give priority to domestic procurement. According to the Ministry of Health Planning and Finance Deputy Director Liu Diankui said, \"five\" will be in China during the economic means to effectively guide the medical use of domestic medical equipment. Ministry of Health\\ s focus on the current procurement projects, the successful devices are made based, in the future development of primary health care institutions in the device configuration standards and arrangements for equipment investment, it will adhere to the relatively low domestic prices as a basis for estimates of medical devices, prompting priority over domestic procurement of medical equipment.
Home medical equipment, very substantial. At present, China\\ s medical device market share of home medical equipment products is too low. According to statistics, the 2010 national total sales of home medical equipment products is only 14 billion domestic medical equipment market, accounting for only 14% of total sales, while in foreign countries this proportion is generally about 25%. Thus, home medical equipment products in China is still a huge space for development.
Hunan Food and Drug Administration requirements: management of medical equipment must be street pavement
\"medical device retail business establishments should be street pavement.\" This is necessary? \"Enterprises purchasing, docking situation and Drug Administration.\" Will not disclose the business secrets? This afternoon, the Provincial Food and Drug Administration expert consultation held in major administrative decisions will be demonstrated in order to improve the \"medical device enterprises in Hunan Province-site inspection standards.\"
Today\\ s demonstration will be invited to the expert advice of experts on behalf of 17 people. The proof will be revised include the following: medical equipment enterprises are divided into two kinds of wholesale and retail, and define their classification, were developed on-site inspection and acceptance criteria.
Medical equipment wholesale business or Class II Class III devices more than five varieties of quality management institutions must be set. Employed as a quality control staff of retirees shall not exceed 65 years of age. Class II and Class III business products, the starting point of 50 million registered capital, 100 million, and according to product variety increase. On the business premises and storage conditions were modified to increase the operating space, warehouse space. Another period of the lease contract requires at least 2 years.
Additional real-time online monitoring of the terms, conditions require companies purchasing, docking with the pharmaceutical sector.
Will operate the hearing aids, contact lenses and other types of retail business merged into a unified enterprise. Medical device retail business establishments should be street pavement.
During the second five will give priority to domestic procurement of medical equipment
2012-2015 period, the central government will consider supporting primary health care institutions with basic equipment, and national, provincial health center construction and support with advanced diagnostic equipment. In addition, the current Ministry of Health\\ s centralized procurement projects, the Ministry of Health have taken certain measures to encourage purchases of domestic medical equipment around the priority. However, compared with foreign medical device companies, medical device domestic enterprises are still weak.
According to reports from 2012 to 2015, central government will consider supporting primary health care institutions with basic equipment, provincial and county levels to enhance CDC test capacity building, institution-building in public health prevention and control of occupational health institution-building, and equipped with necessary equipment; here, will continue to improve rural emergency system, ambulance and first aid equipment will be necessary to gradually increase; provincial and county levels in maternal and child health agencies gynecological treatment, breast transillumination infrared instrument, the fetus ECG and semi-automatic biochemical analyzer expected to become equipped with focus; primary care health education and health institutions have also been included in the central device configuration content to consider the project, health personnel training base equipment building are also taken into account.
Meanwhile, the central will also consider supporting the national, provincial health center construction and support with advanced diagnostic equipment, clinical focus on providing specialist equipment to support the construction and building national, provincial and municipal levels of health information platform.
Liu Diankui noted that the current Ministry of Health\\ s centralized procurement projects, the successful devices are made mainly in the development of primary health care sector equipment investment in equipment configuration standards and arrangements, it will adhere to the relatively low domestic prices as a basis for estimates of medical equipment to promote priority over domestic medical equipment procurement. In 2011, total investment in the rural emergency system $ 720 million general practitioner training bases invested 500 million yuan, food safety risk monitoring system investment of 100 million, with related equipment used.
Still imported equipment market advantage
China\\ s medical device market is huge. Chinese Medicines and Health Products Import and Export Chamber of Commerce, medical director of Caitian Zhi said that the current medical device market in China involving a total of 1708 state-owned enterprises, foreign-funded enterprises 4875, 18,022 private enterprises. Shanghai, Guangdong, Jiangsu, Beijing and Zhejiang is China\\ s medical device trade concentration, the five provinces of China\\ s medical equipment accounted for 70% or more than trade.
However, compared with foreign medical device companies, medical device domestic enterprises are still weak. January-April 2011, China\\ s high share of imports of medical equipment to high-end products mainly. For CT equipment, for example, in 2010 GE, Siemens, Philips, Toshiba, Neusoft and five companies account for the domestic market share up to 92%; MRI equipment, GE, Siemens, Philips three occupy more than 50% domestic market share .
Cai Tianzhi introduced in 2010, China\\ s medical imaging equipment market, sales volume reached 23.4 billion yuan, the scale of home medical equipment up to 27 billion in vitro diagnostics market size $ 15 billion, in addition, cardiac pacemakers, orthopedic implants medical devices, foreign companies accounted for the major markets.
Total paid medical system Pathfinder
This year, the Ministry of Human Resources and Social Security has been brewing in the health care payment mechanisms in more action, and in the outpatient service and capitation payment system is activated, the total payment mechanisms in place to implement once meet resistance. Recently, the Ministry of People s Insurance Health Insurance Secretary, Yao said: "At present, the document issued, many places do not know how to do. Capitation payment total should explore ways to explore the direction is more to the hospital medication autonomy. "
This reporter has learned that China s current health insurance fund is facing the pressure of rising medical costs. According to statistics, China s per capita health expenditure growth of 14%. This time, the Ministry of People s Insurance medical institutions and health care departments want to be able to do risk quintals.
In order to enhance the enthusiasm of medical institutions, the People s Insurance Department will carry out exploration by DRGs, plans to give hospitals more autonomy, the specific course of treatment, the hospital can have more right to the drug of choice.
To achieve this goal, the People s Insurance Department will also reform the management of health insurance directory, Yao said: "The future of drug A and Medicare B directory to gradually eliminate the difference, directory management audit will also change, to quality control to gradually direction of development. "
Annual cost settlement
Total amount of prepaid health care system is Medicare departments of medical institutions in the assessment, to calculate the per capita health care costs, costs of the standard here fixed to the hospital pre-paid medical expenses, if the actual cost overruns, cost overruns in part by the hospitals themselves.
At present, most areas have adopted pay-for-service payment. Than the current Medicare payment, the total pre-paid system to enhance control of medical practices, can effectively improve the health care institution to open a large prescription, chaos checks, arbitrary charges, any expansion of services and other defects.
According to Reporters learned that Shanghai has been the pilot of the total amount paid by the mechanism, health insurance departments are organized every year on the 1-year hospital Medicare to negotiate with the hospital total costs, this amount paid on an annual basis negotiations have been in containing health care expenses rapid growth has played a role.
Yao said: "In the past health care sector is concerned about the budget and settlement of revenue management, is to focus on strengthening expenditure budget management, group management, the various groups need to calculate the settlement amount of expenditure and how much different hospitals and expenditure budget What is the amount. "
For this reason, people carry out in co-ordinating the Department made a "how much money to do many things" concept. According to Yao introduction: "I basically made the calculations, according to these hospitals to calculate the tax-free high-tech enterprises, commercial drugs counted as income tax, business is good."
The health care sector is now facing pressure than in large medical institutions, due to rising medical costs, the threshold current deductibles and payment lines have no control over pay increases.
Total prepaid system, however there are some problems, the total pre-paid method is usually to pay for health care institutions a year total, in this case, the hospital is the biggest risk.
Medical institutions and doctors in order to improve the enthusiasm of the People s Insurance Department plans to phase out the use of medical management and the right medicine to the hospital.
The right medication to be delegated
About how to assess the value of medical services, Yao said: "Medicare should pay for health economics from the perspective of input and output, health insurance departments should also strengthen the research in this area."
In recent years, with investment in improved health care and medical institutions in support of the policy, after years of expansion of development, China s medical institutions, health care quality has also improved, but, once the hospital s total control of a charge in the cost fixed case, how to ensure quality of care? This is a problem faced by medical institutions, but also the challenges facing drug development companies.
According to Yao introduction: "The future medical treatment for full liberalization of the right, according to the DRGs of the pilot hospitals, the patient medication will no longer points A and B drugs, drug use entirely by the hospital to decide how to evaluate hospital , on how to use drugs. "
In addition, the choice of drugs in the directory, the People s Insurance Department has new ideas. Yao said: "The meaning and management of drug prices to adjust the starting point, what is the price of the drug purchase, should cure the patient as a starting point, to consider the economic value of pharmaceutical drugs."
Social Security Medicare national human researcher Dong Zhaohui said: "A new drug program is not cost-effective, we should pay for the new treatment program cost? If this treatment be integrated into the health insurance reimbursement directory, how to be drug list? Last , from the perspective of equity and efficiency, what treatment should be encouraged to limit what treatment options? these issues will be fairness in the assessment and evaluation of the budget in the affirmative. "
China built the world s largest medical insurance system covers more than 12 million people
Up to now, China s basic medical insurance system covers more than 1.25 billion population, to become the world s largest health care system.
Ministry of Health, Medical and Health Services Supervision Division Zong for a long time here at the hospital cross-strait forum (2011) introduced since 1997, the Chinese government to increase the intensity of the medical security system, basic health care system, a breakthrough.
Statistics show that in 2010 the new rural cooperative medical care the number of participants has reached 835 million, accounting for 96.3 percent of the total rural population, urban basic medical insurance and basic medical insurance for urban residents, the number of people insured and 234 million respectively 187 million people, has three basic medical insurance system covers more than 93% of the population of the mainland.
At the same time, when medical assistance is also the year 39,840,000 passengers, medical aid spending 6.55 billion yuan.
Up to now, mainland China has basically completed the basic medical insurance, basic medical insurance for urban residents, the new rural cooperative medical care as the main underpinning of medical aid, the civil service benefits, corporate supplementary insurance, special populations, commercial insurance to supplement the health insurance system .
According to reports, in 2010, China s total health cost of 1.96 trillion yuan, accounting for 5.28% of GDP. To measure the statistics of 2009, government and community health expenditures were accounted for when total health expenditure constituted 27.5% and 35.1%.
Venture capital investment in 2012, executives optimistic about the health care industry sector
Medical industry and TMT (ie digital new media, Technology, Media, Telecom) and by virtue of its broad market prospects increasingly favored by venture capital organizations, over the weekend at the "2011 Halter Financial Summit", the participating venture capital industry executives talk about investment strategy in 2012 have shown the development of these two industry optimistic about the prospects.
Major U.S. venture capital fund KPCB (KPCB) partner of China, Huang Rui Jin pointed out, KPCB investment targets in the choice of the most valued in the relevant areas of its business model is a breakthrough. Based on this, whether it is China or the U.S. market, KPCB focuses on three areas: TMT, green technology and medical industries. As for the investment strategy. Huang Rui Jin believes that the invested enterprise, pattern, of course, is the venture capital product focus, but more from the perspective of market needs analysis to determine. "In the healthcare field, if the leading companies on the market, so whether it is early, mid or late we are willing to put money into it." Huang Rui Jin for example, said.
Gold Stone, vice president of Mi Jie said, Gold Stone focuses on the growth of the invested enterprise, "now I happened to be concerned about the health and medical fields." He also stressed that although not a long term investment and operation of stone, but the summary of past cases, the company For the pursuit of technology assets is very strong, in this context, the fund manager s task is related to in-house technology assets can do for effective assessment. For example, IT, health industry, bio-pharmaceutical industry contain specific, subtle, in-depth technical details, and details of the assessment capabilities of these technologies, often determines whether a given fund s key investment decisions.
Kai Liu Chiba investment partners also expressed a similar view. In her view, in people s clothing, food, shelter, basic conditions are met, the consumer will upgrade the main driver of future economic development. "Our fund s investment focus primarily in TMT, healthcare and other areas in the future, we hope this is a class of investment company that is able to put some of the leading scientific and technology to China, and China s future consumption and thus have more upgrades a good combination. "
Medical lighting market high market capitalization threshold
As a special way of lighting, medical lighting has certain special requirements, compared with conventional medical lighting, LED has directional, low spectral characteristics of injury as their entry into medical lighting field advantage.
It is understood, has a fixed medical lighting, directional lighting, high-intensity light, pure light color (with excellent color rendering, so that doctors can clearly distinguish the structure of different organs and tissues, and the best you can to some extent, as needed color temperature adjustment, to highlight certain organs or tissues) and even, shadowless lighting, low spectral damage, structural sealing sterilization, structural permeability, dimming control, high reliability, and other special needs.
Lighting has long been the traditional medical use halogen light source, in recent years began to use metal halide lamp as the light source. Halogen, metal halide lamps are the light in all directions all the typical spatial divergence divergent light, so that heat radiation, full spectrum, divergence of the light source, to reach medical lighting (surgical shadowless lamp) of the special technical requirements, a series of special techniques must be used . For example, dimming control, halogen achieved by adjusting the light intensity control supply voltage, but the light intensity changes will affect the color temperature and color rendering and so on.
Replaced with new LED light source, represented by the conventional halogen light source, in clinical surgery lighting, lighting, medical examination and medical diagnosis and treatment of lighting will help in improving the medical institutions, clinical diagnosis and surgical treatment of quality at the same time, green lighting.
Lighting consists mainly of general medical check lighting, surgical lighting, lighting treatment categories. Which the operation shadowless lamp, dental lamp lighting operation is represented by the highest technical difficulty, the most stringent security requirements, the highest price, a typical representative of the most complex designs. Also some industry analysts pointed out that in the medical field, in addition to surgical shadowless lamp, the local check lighting, such as oral lights, endoscopic light; for area lighting in the operating room lights, surgical lights ready; for the treatment of specific diseases light therapy equipment, such as photodynamic therapy apparatus, neonatal jaundice treatment, UV disinfection lamps, etc., are suitable for the promotion of LED medical lighting.
From a market perspective, the unique technical requirements and features make to the medical surgical shadowless lighting represented a very special lighting products in the product, it must be managed in accordance with the regulations of medical devices, through a rigorous assessment of clinical trials, access to medical equipment product license. Therefore, high-tech, high-risk, high barriers to entry of specialty lighting products, lighting products to avoid facing the conventional cut-throat competition situation.
In addition, although the medical lighting high barriers to entry, a large technical difficulties, but only medical device of a \"small\" segment of the market, most large medical device companies to operate only in passing medical lighting products, very few professional manufacturers, so market price of expensive medical lighting products, lighting the formation of high prices, semiconductor lighting products in any other area of ??a common lighting problems facing severe price, in the medical lighting effects are relatively less acute.
High barriers to entry due to medical lighting, small markets, but the market is expensive, so the actual market value of its large market. Medical lighting can be the best starting point is one of the semiconductor lighting.
Capital fought over health care chain
Health sector of the capital market in 2010 was a very eye-catching: inside and outside the healthcare industry as an initial public offering (IPO) one of the largest number of four industries; the average IPO book industries and enterprises the highest return on investment is the healthcare industry industry, the average investment rate of return of 18.68 times.
And health care services throughout the healthcare industry, the growth plates are also outstanding shares. Fifth China Healthcare Industry Investment and Financing Summit disclose figures, from the sub-industry point of view, the original thriving pharmaceutical industry, accounting for 70% of the total financing, to 2010 the proportion fell to 50%, the remaining significant growth from the medical services and medical equipment, especially the former.
\"China\\ s medical needs are long-term sustainable growth, unlike the automobile, telecommunications and other sectors of the growth curve is S-shaped, up to a certain peak that is the turning point, while the medical industry is basically showing linear growth, we are particularly optimistic about the industry.\" direct investment in the company general manager Jin Chen, Yu said at the summit.
Number of private medical institutions to find financing, venture capital for high-quality projects, listed companies and multinational corporations seek seek acquisition opportunities, a variety of needs in the marriage of capital and exchange platform for the medical industry on the corner. And wish to take a slice of the capital market more and more medical institutions. Legend Capital, General Manager Liu Zehui this proposal, \"the leadership of medical institutions bear the greatest risk and responsibility, especially after the introduction of investors, the pressure will be greater, should the purpose of financing, future planning should think carefully, do not order financing and financing. \"
As the public hospital system, reorganization of the detention policy, institutional investors have to take a detour, only bent on private medical institutions. Avenue CapitalGroup Zan Tao, executive director, said: \"Avneue funds invested in the UK a large 1,500-bed hospital, while in China there is no such opportunity. China is now the policy to the social capital is indeed a good imagination, but the tax , human resources, incentive compensation and other supporting policies are not in place, investors have a high-end medical experts can not enter the large public hospitals, not only turned to a private high not low secondary hospitals as investors involved more deeply in love with the privatization of public hospitals, investment the opportunity. \"
Specific to health care institutions, investors place great emphasis on investment targets of the management team. CDH Executive Director Wang Hui said: \"We invested a total of four medical institutions in the Hospital is the hospital, house, equipment in place, the specific operation to be enforced, the time involved in the implementation process, quality of service and other details as investors We have no way to help, but also they have the management strength of the hospital. \"
Shenzhen Capital Group, Liu Gang, general manager of Beijing also shared: \"We are investing in the hospital, tend to find the best professional management team, want to have a strong core management synergy, because the highly specialized treatment services, There should be a core team. \"
Investment institutions to invest funds into the object, the two form a close community of interests, the former often also provide additional support as a value-added services.
Chen, Yu introduced the gold companies to invest in two medical institutions, compared to other industries, investment in the medical industry to spend on doing up the value-added services to help invest in the top three hospitals and medical institutions to establish co-operation, a large hospital for the medical expert resources , and even help them replicate the chain of medical institutions, participation, including holding a license, looking for an apartment, to get to such trivial things.
In fact, the medical services in the healthcare industry\\ s share is not large. \"If the health care equivalent to hospital, then the investment opportunities in China are very small. The gradual improvement in the external policy environment, investors may wish to invest in some proper extension of the border, focusing on the entire health industry chain, which is still very pragmatic tactics. \"Liuze Hui said.
Regional health information technology system
1, to determine the implementation of the main
The current implementation of a regional health information to hospitals or university as the center, but also lead to medical management center, but also to the government to operate. Not the same as the level of institutions at all levels, throughout the construction of the participating units are not the same. Overall, the regional medical information need to coordinate the process of building multiple resources, recommended by the government organizations, and government operation and maintenance management. The establishment of a government led by capable, efficient command and decision system, clarify the responsibilities of work organization and work flow.
2, the overall structure of information
Medical information generally go through three stages: the stage of the hospital management information, clinical stage and regional management information medical information phase. First, you must first do-based information systems, such as the first on the HIS (Hospital Information System), and on this basis, continuously RIS (radiology information system), LIS (Laboratory Information Management System), PACS (medical imaging archiving and communication system) and other connected up, then CIS (Clinical Information System) after the next to do is to public health information system (CHSS system), an integrated hospital information system by medical services, health education into the family, followed by promote management service platform, such as e-government, health care information management and medical e-commerce platform.
3, the structure of information resources
First, starting from the national level to "opinions on deepening the health care reform" as a guide, as soon as possible national health information model. From the information point of view, definition of medical institutions at all levels of the main functions, responsibilities, tasks and scope of medical institutions and medical institutions, and other agencies, such as funding and the relationship between institutions; followed by the establishment of Regional Medical Resource Center responsible for regional medical establishment and a variety of information resources to collect, maintain, and improve the medical management software repository and the co-ordination of planning.
4, tools and standards
Organization-related professionals, with reference to the corresponding international standards, define for all types of health care industry events, news and events related to the structure, data types, data formats, the development of message exchange engine, the message encoding and decoding, and through the data exchange standard version of the upgrade, maintenance, to achieve dynamic update message structure. In the process of regional health information, support and encourage the use of open standards for health information platform, and to explore the hospital, community, public health agencies collaborative model, business process innovation and so on.
5, information integration architecture
Regional integration is the focus of health information technology implementation, by means of effective information systems, and properly handle the various relationships between health care institutions. In the health authorities and medical institutions to implement an integrated management information system, government, hospitals, scientific research, disease surveillance, government, community health and family in a unified technology platform to carry out the operation, and the coordinated development of the plate to provide support for linkage .
6, information technology infrastructure
Only grass-roots public health agencies and all levels of the hospital s own information up to a certain extent, the regional health information technology has been considered basic. Therefore, to effectively build health service infrastructure, including regional health centers, specialty hospitals, health oversight agencies, CDC, reproductive health, health service centers and the various units of their own information, such as intra-hospital medical imaging, video conferencing, voice services (including VoIP), wireless access, environmental control, building access control, monitoring and other biomedical data applications.
7, protection and security system
Regional health information projects, need to be protected by a series of measures implemented, including policies and regulations on protection, organization and personnel to ensure and sources of funding, the government, business and community wide support and participation. In addition the building security system is also very important, health personal health record system in a number of privacy issues involved, patient medication database related to the hospital with the economic interests and social benefits. Therefore, in the process of regional health information must be information storage and transmission of information security to be considered.
In summary, the regional health information technology is the power in the interest of future generations of systematic social engineering of complex, regardless of their background or the proposed benefits to society are far-reaching significance. Its purpose is coordination and integration of public health, medical services and other fields, to achieve interoperability, efficiency and quality of health services management to create a truly patient-centered health care system the region to achieve the information, the consistency of business and management , continuity, effectiveness and control, medical and health services for the Chinese to make a contribution.
PwC: Chinese medical innovation to catch up with Europe in 2020
\"China, India, Brazil, led by emerging markets innovative medical technology is constantly improved. The next 10 years, innovation in the medical field in emerging markets may be more than developed countries.\" World-renowned accounting firm PricewaterhouseCoopers has released the latest report on \"Medical Technology Innovation Scorecard: competition for the world\\ s leading competition,\" said the emerging markets with their own development, is attracting a growing number of innovative resources and activities in an effort pioneered the development of a new generation of small, efficient and more expensive medical equipment.
Advantage of weakening the United States
PricewaterhouseCoopers in Brazil, China, France, Germany, India, Israel, Japan, Britain, the United States and other nine countries had the ability to adapt to changes of an innovative new, multi-faceted assessment.
According to reports, a large number of case studies that, in the leading position of the United States is losing its global innovation center.
PwC report that: medical technology innovation, the United States is still the world leader status. The next 10 years, the United States will continue to show their strongest ability to lead innovation in medical technology innovation, but the leadership will be weakened.
Over the past few decades, the United States to become a leader in medical technology innovation, there are five pillars of this report the five pillars of the nine countries were evaluated. These five pillars are: a strong economic power, such as new technology applications for compensation; innovative resources, such as academic medical centers; supporting regulatory system; demand and price-insensitive patients; by the venture capitalists and other investors constitute a secondary investment groups.
The report notes that with the innovative features of the change, the ideal innovation system itself is also changing. Some of these changes by the United States itself factors, such as new medical technologies in order to certification by regulatory agencies, the cost is getting higher and higher, the results are more difficult to predict; the medical field more and more emphasis on low cost, high value solution programs; R & D investment is becoming more international. Another change will depend on changes in the market outside the United States, for example: the market for investment in local academic medical centers increased; for research projects; many foreign educated scientists and doctors to return to work; mobile medical technology continues to develop , medical channels to increase; these markets are more focused on providing fast, quality, affordable, effective health care solutions.
Attractive emerging markets
Given these factors, medical technology companies increasingly turn to outside the United States to collect clinical data, registration of new products, new markets, those markets have become more attractive and more conducive to innovation. For example, a great number of innovative products into the U.S. before, first select European markets, 2020 may be selected emerging market countries.
PricewaterhouseCoopers U.S. pharmaceutical and medical device industry executives Maike Si Wan Nick (Mike Swanick) said: \"social, demographic, economic, technological and other changes in the combined effects of medical technology is changing the pattern of the world in many countries around the established to encourage innovation in the system – with reasonable financing channels, the necessary scientific knowledge and the interaction with the patient as long as able to adapt to this rapidly evolving environment, the changes to the company or the entire country will be able to create opportunities. \"
The report predicts, Japan, Israel, France, Britain, Germany\\ s innovation capacity will be reduced, while China, India, Brazil, innovation may be enhanced. Over the past five years, China\\ s fastest growing innovation capability, the future will continue to maintain the momentum of rapid development is expected in 2020 than other developing countries and developed countries in Europe to catch up with the level of innovation.
However, according to the forecast: China, India, Brazil and other markets although large, but not necessarily to become the leading force of innovation in medical technology. Because inadequate intellectual property protection, foreign-funded enterprises operating difficulties in some countries, coupled with factors such as underdevelopment of local supply networks, making these markets less attractive, in its efforts to become a global leader in innovative power of the process will also be affected.
\"At present, China\\ s research output in second place, the university leadership, ranked fifth, with Germany, Japan, Britain and other less.\"
PricewaterhouseCoopers director Christopher Westin medical industry (Christopher L. Wasden) pointed out: the difficulty of entering the Chinese market is still relatively high, approved a long time, only Japan is more difficult than China, which to some extent hindered the new technology market.